Seoul Pharma Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Seoul Pharma Co Ltd

Watchlist Manager

Watchlist

Price: 1 970 KRW -0.71% Market Closed

Market Cap: ₩23B

S	Seoul Pharma Co Ltd KOSDAQ:018680	KR
	Hold Me Ltd OTC:HMELF	IL
	Petro Victory Energy Corp XTSX:VRY	US

Profitability Summary

Seoul Pharma Co Ltd's profitability score is 42/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

61%

Declining Gross Margin

64% > 60%

Negative Operating Margin

-3%

Low 3Y Average Operating Margin

Declining Operating Margin

5% > -3%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

9% > 1%

Exceptional Free Cash Flow Margin

20%

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

View All

Hide

Collapse

42 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.